The Latest Selloff Is the Perfect Buying Opportunity for Nvidia and Broadcom

Nvidia is down ~18.5% and Broadcom down ~24.4% from recent highs, which the article frames as a potential buying opportunity amid an AI capex “bearish sentiment cycle.” It highlights Broadcom’s guidance that AI semiconductor revenue will exceed $100B by 2027 and expects Broadcom revenue to rise to $172B next year (+62%), alongside Nvidia’s view that AI hyperscaler capex could top $1T next year (from $650B in 2026). Overall, the news is bullish on forward fundamentals/visibility but grounded in valuation support rather than a fresh catalyst.

Analysis

The selloff looks more like multiple de-rating than a deterioration in fundamental demand, but the market is now forcing a distinction between “AI beneficiary” and “AI operating leverage.” In the next 1-3 months, the stocks should trade primarily on hyperscaler capex commentary and whether management teams reaffirm 2026-2027 build schedules; absent that, rebounds are likely to fade as investors demand proof that AI spend is translating into revenue acceleration rather than just larger budgets. The second-order risk is that AI capex can remain high while mix shifts away from pure GPU demand toward custom silicon, which would support AVGO more than NVDA at the margin.

Over 6-18 months, the more interesting setup is relative-share capture inside the AI stack: AVGO has a clearer path to content expansion if custom ASIC adoption continues, while NVDA still owns the ecosystem but is more exposed to any digestion in leading-edge GPU orders. If hyperscalers continue to prioritize cost/performance efficiency, that benefits custom chip architectures and could compress NVDA’s growth multiple relative to AVGO even if absolute revenues keep rising. The contrarian view is that the market is underestimating how long AI capex can stay elevated, but overestimating how uniformly that spending accrues to every semiconductor winner.

The main reversal risk is a single quarter of softer capex commentary from MSFT/GOOGL/AMZN or any sign that customer inventory is normalizing faster than orders. If that happens, the trade shifts from “buy the dip” to “sell the high-beta AI complex,” with NVDA likely to react harder than AVGO because its valuation is more dependent on sustained step-function growth. Until then, the current drawdown looks more like a relative-value opportunity than a clean all-clear signal.

Key Decisions for Investors

• Prefer long AVGO vs. long NVDA on a 1-3 month horizon if the thesis is AI spend durability plus mix shift to custom silicon; target a relative outperformance trade rather than outright beta.
• If buying the dip in AI semis, stage entries on post-earnings or post-capex-confirmation weakness rather than chasing intraday rebounds; the catalyst is guidance, not sentiment.
• Use SMH or SOXX as the cleaner expression of AI semiconductor beta if the goal is broad capex exposure; hedge with a smaller NVDA underweight to isolate relative share risk.
• Set a hard falsifier: any hyperscaler commentary implying 2026 AI capex growth below current expectations should reduce exposure immediately, especially in NVDA.
• For longer-term portfolios, keep AVGO as the higher-quality AI compounder and treat NVDA as the higher-beta trade; if the market keeps rewarding “efficiency” over “performance,” AVGO should hold up better on drawdowns.